To test this hypothesis, we transplanted luciferase- and GFP-labelled p53-wildtype murine lymphoma EL4 cells into mice via the tail vein, and tumour cell proliferation was then monitored by whole-body imaging for luciferase activity and flow cytometry analysis for GFP expression. The gene discussed is TP53; the disease is neoplasm.